Bibliografía del artículo
1. Jacobs, M. A history of digitalis therapy. Ann Med Hist 8: 492-499, 1936.
2. Smith TW. Digitalis. Mechanisms of action and clinical use. N Engl J Med 318:358, 1988.
3. Somberg J, Greenfield P and Tepper D. Digitalis: historical development in clinical medicine. J Clin Pharm 25: 484-489, 1986.
4. Gheorghiade M, Veldhuisen D, Colucci W. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 113: 2556-2564, 2006.
5. González P, Lázaro E, Cuena R, Rodríguez L. La digoxina, hoy. Inf Ter Sist Nac Salud 27: 115-123, 2003.
6. Pastelin G. Farmacología de los agentes inotrópicos. Arch Cardiol Mex 72: S156-162, 2002.
7. Connolly S, Camm A, Halperin J, Joyner C, Alings M, Amerena J, Atar D, Avezum A, Blomstróm P, Borggrefe M, Budaj A, Chen S, Ching C, Commerford P, Dans A, Davy J, Delacrétaz E, Pasquale G, Diaz R, DorianP, Flaker G, Golistsyn S, González-Hermosillo A, Granger C, Heidbúchel H, Kautzner J, Kimm J, Lanas F, Lewis B, Merino J, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters Ni, Sim K, Stiles M, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse H, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu J, Baret , Cormel L, Pharm E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser S, for the PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Eng J Med 365: 2268-76, 2011.
8. Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol. Jun 4 69(18):108G-118G; disc. 118G-119G, 1992.
9. Gheorghiade M, St Clair J, St Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 9:849, 1987.
10. Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 13:134, 1989.
11. Lee DC, Johnson RA, Bingham JB et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 306: 699, 1982.
12. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol 61: 371-380, 1988.
13. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 259(4):539-544, 1988.
14. Di Bianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320:677, 1989.
15. Alicandri C, Fariello R, Boni E, et al. Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study. J Cardiovasc Pharmacol 9: S2-S61, 1987.
16. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial: PROVED Investigative Group. J Am Coll Cardiol 22: 955-962, 1993.
17. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van VL, Gourley LA, Jolly MK, for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study. N Engl J Med 329:1-7, 1993.
18. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525-533, 1997.
19. Bavishi C, Rahman A, Ather S. Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis. Int J Cardiol 188: 99-101, 2015.
20. Turakhia M, Santangeli P, Winkelmayer W, Xu X, Ullal A, Than C, Schmitt S, Holmes T, Frayne S, Phibbs C, Yang F, Hoang D, Ho M, Heidenrech P. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation. Findings from the TREAT-AF study. JACC 64(7): 660-668, 2014.
21. Washam J, Stevens S, Lokhnygina Y, Halperin J, Breithardt G, Singer D, Mahaffey K, Hankey G, Berkowitz S, Nessel C, Fox K, Califf R, Piccini J, Patel M, for the ROCKET AF Steering Committe and Investigators. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Lancet Online advance, 2015.
22. Olshansky B, Rosenfeld L, Warner A, Solomon A, Rosenfeld L, Sharma A, Platia E, Feld G, Akiyama T, Brodsky M, Greene L and the AFFIRM investigators. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Approaches to control rate in atrial fibrillation. J Am Coll Cardiol 43 (7): 1201-1208, 2004.
23. The AFFIRM investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109: 1509-1513, 2004.
24. Whitbeck M, Charnigo R, Khairy P, Ziada K, Bailey A, Zegarra M, Shah J, Morales G, Macaulay T, Sorrell V, Campbell C, Gurley J, Anaya P, Nasr H, Bai R, Biase L, Booth D, Jondeau G, Natale A, Roy D, Smyth S, Moliterno D, Elayi C. Increased mortality among patients taking digoxin-analysis from de AFFIRM study. Eur Heart J 34: 1481-1488, 2013.
25. Gheorghiade M, Fonarow G, Veldhuisen D, Cleland J, Butler J, Epstein A, Patel K, Aban I, Aronow W, Anker S, Ahmed A. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched. Eur Heart J 34: 1489-1497, 2013.
26. Freeman J, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki N, Borowshy L, Harrison T, Singer D, Go A. Digoxin and risk of death in adults with atrial fibrillation: The ATRIA-CVERN study. Circ Arrhythm Electrophysiol 8(1): 49-58, 2014.
27. Rodríguez-Mañero M, Otero-Raviña F, García-Seara J, Zugaza-Gurruchaga L, Rodríguez-García J, Blanco-Rodríguez R, Turrado V, Fernández-Villaverde J, Vidal-Pérez R, González-Juanatey J. Seguimiento clínico de una muestra contemporánea de pacientes con fibrilación auricular en tratamiento con digoxina: resultados del estudio AFBAR. Rev Esp Cardiol 67(11): 890-897, 2014.
28. Ouyang A, Lv Y, Zhong H, Wen J, Wei X, Peng H, Zhou J, Liu L. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol 115: 901-906, 2015.
29. Vamos M, Erath J, Hohnloser S. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. European Heart journal 36: 1831-1838, 2015.
30. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787-1847, 2012.
31. Yancy C, Jessup M, Bozhurt B, Butler J, Casey D, Drazner M, Fonarow G, Geraci S, Horwich T, Januzzi J, Johnson M, Kasper E, Levy W, Masoudi F, McBride P, McMurray J, Mitchel J, Peterson P, Riegel B, Sam F, Stevenson L, Tan W, Tsai E, Wilkoff B. 2013 ACCF/AHA Guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128: e240-e327, 2013.
32. Camm J, Kirchhof P, Lip G, Schotten U, Savelieva I, Ernst S, Van Gelder I, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, Sutter J, Goette A, Gorenek B, Heldal M, Hohloser S, Kolh P, Le Heuzey J, Ponikowski P, Rutten F. Guidelines for the management of atrial fibrillation. The Task Force for the management of atrial fibrillation of the European Society of Cardiology. European Heart Journal 31: 2369-2429, 2010.
33. January C, Wann S, Alpert J, Calkins H, Cigarroa J, Cleveland J, Conti J, Ellinor P, Ezekowitz M, Field M, Murray K, Sacco R, Stevenson W, Tchou P, Tracy C, Yancy C. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21): 2246-2280, 2014.